PROCTER & GAMBLE HEALTH
|
The Current P/E Ratio of PROCTER & GAMBLE HEALTH is 40.53.
Share Price | ₹5,316.1 | Jan 14,2025 |
Market Cap | ₹8,824.7 Cr | |
Earnings-TTM | ₹217.7 Cr | TTM-Standalone Results |
Price/Earnings | 40.53x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PROCTER & GAMBLE HEALTH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹8,824.7 Cr] as on Jan 14,2025
(/) Earnings [ ₹217.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 40.53x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay 40.53 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PE (Price/Earnings) ratio chart of PROCTER & GAMBLE HEALTH
PE Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Jun2024 to Jun2020 averaged 38.97x.
- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 37.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Jun2021 at 52.52x.
- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2020 of 26.57x.
How does PROCTER & GAMBLE HEALTH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 217.74 | 40.53 | 8,824.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.11 | 424,382.0 |
CIPLA LTD | 4,485.22 | 26.07 | 116,943.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.64 | 111,588.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.43 | 100,704.0 |
DIVIS LABORATORIES LTD | 1,836.00 | 86.72 | 159,224.0 |
MANKIND PHARMA LTD | 2,124.86 | 51.87 | 110,215.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 61.12 | 110,142.0 |
LUPIN LTD | 2,651.94 | 37.08 | 98,330.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.96 | 68,238.4 |
ABBOTT INDIA LTD | 1,284.66 | 46.74 | 60,041.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PROCTER & GAMBLE HEALTH 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.96x |
Max industry PE | 86.72x |
Median industry PE | 38.11x |
Average industry PE | 41.02x |
You may also like the below Video Courses